Zhe Sha, Harvard Medical School, USA
Its my real honor to be part of this great conference. I had a truly rewarding experience meeting with many experts in the field.
Jamal Abdel-Halim, Director, Biomarkers, USA
It was my pleasure to participate and speak in this important meeting. I wish we work together again.
OMICS Group International -The scientific hub that possesses the unique and the second-to none feature, because of the best published articles and eminent International conferences organized throughout the year. The salient features of are Open Access Journals which are 400, a Team of 30, 000 editorial members along with a reviewing team of 35,000 and more that 1,30,000 followers on social networks and most essentially 3.5 million readers. The associations, the societies and the collaborations mark OMICS Group International at its best. Hence it sustains the best and the current research articles in the Open Access Group besides approaching the world of scientists by OMICS Group Conferences is proud to host around 300 international conferences around the globe to address the current issues and discoveries in the field of Life sciences, Engineering & Applied Science, Omics and Management, Clinical, Medical and Pharmaceutical sciences.
Pharmacovigilance-2013 annual conference reflected the development of Pharmacovigilance, drug safety and clinical trials from a new to a mature industry, highlighting through various sessions how the science is having an impact on society, and how it can generate even greater impact. Following on from the success of last year now it’s time to invite you all for 3rd International Conference and Exhibition on Pharmacovigilance & Clinical Trials is set to take centre stage once more in Hyderabad India on October 27-29, 2014.
Our conference mainly focused on the Theme “Safer Drugs to Market by Analyzing Latest Developments in Pharmacovigilance, Drug Safety and Risk Management”
Over the last couple of decades, advances in biomedical science have generated more new and complex medicines to treat a broader range of diseases and conditions than ever before. The number of people taking medications has increased dramatically, and, as a result, governments, patient groups and health advocates are demanding stronger regulatory practices and procedures, to assure the safety of medicines before and after they reach the market.
Hence, as the regulatory landscape continues to evolve it is crucial that you are keeping abreast of the changes impacting the drug safety industry to ensure that your pharmacovigilance strategies are robust and geared to compliance. In addition to this effective risk management and minimisation efforts and comprehensive benefit: risk analysis of drugs must lay the foundations for a strong drug safety strategy.
Pharmacovigilance-2014 conference is being collaborated with Society of Pharmacovigilance, India and also we will be collaborated with many more in future. This educational 3 day conference provides a unique platform for workshops and sessions you like to address the practical approaches which can take to mitigate risks and maximise patient safety. A tailored conference will give you the opportunity to share knowledge and expertise and will provide unparalleled networking opportunities with a large number of professionals in this industry sphere.
Pharmacovigilance and its Challenges
Role of Clinical Trials
Clinical Trials on Diseases
Adverse Drug Reactions
Pharmacokinetics and Pharmacodynamics
Pharmacy Practices and its Challenges
Risk Management: New Approaching Paradigm for Pharmacovigilance
Clinical Research and Statistics
Strategies for Growth in Pharma Environment
Good Pharmacovigilance Practice and Pharmacoepidemiology
Case Report in Clinical Trials